Turning a MedSpa's Membership Program Into Financeable Revenue

Pull your last twelve months of revenue apart into monthly membership dues and one-time treatment sales, package purchases, single visits, retail product. Many practices report these together, which understates how strong the membership program actually is on its own. A clean split is the necessary starting point for every step that follows in this process.

A membership program with easy month-to-month cancellation and a documented retention rate is exactly the kind of revenue Pipe was built to advance against, provided churn is low enough to demonstrate real predictability. If your program has no formal terms, patients paying informally on a recurring card charge with no signed agreement, formalizing that into an actual written membership agreement is worth doing before you approach any lender at all.

A medspa membership, even a strong one, doesn't reach Capchase's contracted, SaaS-style annual recurring revenue bar, since most membership programs in this space run month-to-month rather than under multi-month committed terms. Unless you've built annual membership tiers with real cancellation friction, expect this step to end quickly, and move on to evaluating Pipe on the merits of your monthly membership data instead, which is where the more productive conversation actually lives.

Capital equipment, lasers, devices, and injectable inventory carry their own financing needs that a revenue-based advance doesn't address well. Equipment financing secured by the device itself typically costs less than an unsecured advance, so keep that financing conversation separate from what you're doing with membership revenue, rather than trying to solve both with one product. Injectable inventory in particular tends to be a working capital drain on its own, since it's often prepaid or paid on short terms well before the treatments using it get billed.

A lender generally cares more about how long members stay than how fast new members sign up, since enrollment growth that masks high churn isn't durable revenue. Track cohort retention month over month, the same way a subscription business would, and be ready to explain any seasonal dips, since aesthetic and wellness spending often shifts with the calendar in ways a lender will want understood rather than treated as a red flag. A practice that can point to the same seasonal pattern repeating for two or three years running has a much easier time explaining a dip than one seeing it for the first time.

Once you have a formal, signed membership agreement, twelve months of cohort retention data, and membership revenue reported separately from treatment sales, you have a genuinely strong case for Pipe. Bring that package rather than a general pitch about practice growth, since the specific documentation is what actually moves an underwriting decision forward.

Bring this package to a Pipe conversation:

• A signed membership agreement with clear cancellation terms, not just a recurring card charge.
• Twelve months of cohort retention data showing how long members stay.
• Membership revenue reported separately from treatment sales, package purchases and retail product.
• Device and equipment loan payments presented apart from the membership revenue story.

If the practice is expanding to additional locations, build the same membership tracking into each new site from day one rather than retrofitting it later; a story built on one strong flagship location and several newer, unproven ones is weaker than consistent data across every site. Separately, keep equipment loan payments out of the membership revenue story: present device and laser financing as its own line item with its own repayment schedule, rather than letting it blend into your overall debt picture and muddy how an underwriter reads the balance sheet.

A medspa built around one or two key injectors can see membership utilization dip sharply when that provider is out for an extended period, even if dues keep getting collected. That gap between paid membership and delivered service is worth tracking separately, since a lender may ask what happens to retention if a key provider leaves, and a credible answer, cross-training, a bench of licensed providers, standing protocols, strengthens the pitch. Medical oversight and licensing requirements vary by state too, and having a clear, documented answer ready removes a question that could otherwise slow down underwriting, particularly if you operate across more than one state.